StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note released on Friday morning. The firm issued a hold rating on the stock.
China Pharma Price Performance
Shares of CPHI stock opened at $0.18 on Friday. The company has a 50 day moving average price of $0.26 and a 200-day moving average price of $0.34. The company has a current ratio of 0.89, a quick ratio of 0.25 and a debt-to-equity ratio of 0.17. China Pharma has a 52 week low of $0.17 and a 52 week high of $1.77.
China Pharma (NYSE:CPHI – Get Free Report) last announced its earnings results on Wednesday, May 15th. The company reported ($0.07) earnings per share (EPS) for the quarter. China Pharma had a negative net margin of 55.42% and a negative return on equity of 54.31%. The business had revenue of $1.37 million for the quarter.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- From Tokyo to Wall Street: Japan’s Market Impact on U.S. Stocks
- Top Stocks Investing in 5G Technology
- Arm Holdings: Does the 42% Drop Signal an AI Buying Opportunity?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Texas Roadhouse Stampedes On EPS Beat as Comp Sales Surge 9.3%
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
